678 related articles for article (PubMed ID: 16778335)
1. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
2. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats.
Kanematsu Y; Tsuchiya K; Ohnishi H; Motobayashi Y; Izawa Y; Ishihara M; Ishizawa K; Abe S; Kawazoe K; Tamaki T
Hypertens Res; 2006 May; 29(5):369-74. PubMed ID: 16832158
[TBL] [Abstract][Full Text] [Related]
4. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
[TBL] [Abstract][Full Text] [Related]
5. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.
Azegami T; Sasamura H; Hayashi K; Itoh H
Hypertens Res; 2012 May; 35(5):492-9. PubMed ID: 22158111
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
8. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
[TBL] [Abstract][Full Text] [Related]
9. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
13. Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats.
Kato N; Liang YQ; Ochiai Y; Birukawa N; Serizawa M; Jesmin S
Hypertens Res; 2008 Oct; 31(10):1963-75. PubMed ID: 19015604
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
15. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
[TBL] [Abstract][Full Text] [Related]
16. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
[TBL] [Abstract][Full Text] [Related]
17. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
[TBL] [Abstract][Full Text] [Related]
18. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
19. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
Demeilliers B; Mimran A; Jover B
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
